Patient Guide: A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06625333
Status: 🟢 Enrolling Now
Condition: HR+HER2- Advanced Breast Cancer
Phase: Research Study

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • Arkhangelsk,
  • • Barnaul,
  • • Bryansk,
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation - Join Clinical Trial NCTNCT06625333

How to Join This Clinical Trial - NCTNCT06625333

Learn how to participate in this clinical trial studying an investigational therapy for HR+HER2- Advanced Breast Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HR+HER2- Advanced Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HR+HER2- Advanced Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06625333 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Arkhangelsk, 163045 - Russian Federation

Status: RECRUITING

Clinical Research Site

Barnaul, 656045 - Russian Federation

Status: RECRUITING

Clinical Research Site

Bryansk, 241028 - Russian Federation

Status: RECRUITING

Clinical Research Site

Chelyabinsk, 454080 - Russian Federation

Status: RECRUITING

Clinical Research Site

Ekaterinburg, 620036 - Russian Federation

Status: RECRUITING

Clinical Research Site

Irkutsk, 664035 - Russian Federation

Status: RECRUITING

Clinical Research Site

Kemerovo, 650036 - Russian Federation

Status: RECRUITING

Clinical Research Site

Khabarovsk, 680042 - Russian Federation

Status: RECRUITING

Clinical Research Site

Khanty Mansiysk, 628012 - Russian Federation

Status: RECRUITING

Clinical Research Site

Kirov, 610021 - Russian Federation

Status: RECRUITING

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for HR+HER2- Advanced Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships